Transgenomic Research and Development Expenses 2010-2024 | PRPO
Transgenomic research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Transgenomic Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $2 |
| 2014 | $2 |
| 2013 | $3 |
| 2012 | $2 |
| 2011 | $2 |
| 2010 | $2 |
| 2009 | $3 |
| Transgenomic Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $0 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.015B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.366B | 20.52 |
| Inspire Medical Systems (INSP) | United States | $4.612B | 0.00 |
| Axonics (AXNX) | United States | $3.446B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.129B | 0.00 |
| 10x Genomics (TXG) | United States | $2.980B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.950B | 0.00 |
| Enovis (ENOV) | United States | $2.875B | 21.31 |
| Azenta (AZTA) | United States | $2.743B | 154.15 |
| Privia Health (PRVA) | United States | $2.016B | 112.67 |
| Schrodinger (SDGR) | United States | $1.654B | 0.00 |
| Omnicell (OMCL) | United States | $1.398B | 48.32 |
| Phreesia (PHR) | United States | $1.393B | 0.00 |
| Standard BioTools (LAB) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
| Talkspace (TALK) | United States | $0.467B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.442B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
| Pulmonx (LUNG) | United States | $0.349B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.191B | 0.00 |
| Outset Medical (OM) | United States | $0.187B | 0.00 |
| American Well (AMWL) | United States | $0.145B | 0.00 |
| TruBridge (TBRG) | United States | $0.134B | 7.19 |
| 111 (YI) | China | $0.111B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.107B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.064B | 0.00 |
| Augmedix (AUGX) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.042B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.010B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |